Cargando…

Genomic landscape of lung adenocarcinomas in different races

BACKGROUND: Lung adenocarcinoma is a molecularly heterogeneous disease. Several studies, including The Cancer Genome Atlas Research Network (TCGA) and Lung Cancer Mutation Consortium (LCMC), explored the genetic alterations among different ethnic groups. However, minority groups are often under-repr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Huashan, Seegobin, Karan, Heng, Fei, Zhou, Kexun, Chen, Ruqin, Qin, Hong, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557241/ https://www.ncbi.nlm.nih.gov/pubmed/36248982 http://dx.doi.org/10.3389/fonc.2022.946625

Ejemplares similares

Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer
por: Zhou, Kexun, et al.
Publicado: (2021)

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
por: Seegobin, Karan, et al.
Publicado: (2021)

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
por: Wiest, Nathaniel, et al.
Publicado: (2021)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report
por: Majeed, Umair, et al.
Publicado: (2023)

Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literature
por: Seegobin, Karan, et al.
Publicado: (2020)

Brief report: risk stratification following curative therapy for stage I NSCLC
por: Butts, Emily, et al.
Publicado: (2023)

Trends in participant race and sex reporting in lung cancer phase III clinical trials
por: Aslam, Faaiq N., et al.
Publicado: (2023)

Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
por: Majeed, Umair, et al.
Publicado: (2021)

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
por: Yin, Xiang-Qian, et al.
Publicado: (2022)

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023)

Genomic landscape of lung cancer in the young
por: Ruiz, Rossana, et al.
Publicado: (2022)

Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma
por: Yekedüz, Emre, et al.
Publicado: (2022)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Immunotherapies targeting stimulatory pathways and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021)

Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape
por: Lin, Dong-Liang, et al.
Publicado: (2021)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
por: Ashok Kumar, Prashanth, et al.
Publicado: (2023)

Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure
por: Dai, Shun-Dong, et al.
Publicado: (2021)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape
por: Dong, Lingjun, et al.
Publicado: (2023)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape
por: Zhu, Ankang, et al.
Publicado: (2023)

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma
por: Feng, Alei, et al.
Publicado: (2022)

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component
por: Li, Peng, et al.
Publicado: (2022)

Case Report: Termination of unplanned pregnancy led to rapid deterioration of non-small-cell lung cancer during osimertinib treatment
por: Ma, Qizhi, et al.
Publicado: (2023)

Crizotinib‐associated renal cyst development may be associated with prolonged progression‐free survival in patients with ALK‐positive non‐small‐cell lung cancer: Case report and review of the literature
por: Wiest, Nathaniel E., et al.
Publicado: (2021)

Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
por: Yang, Xiaohuang, et al.
Publicado: (2022)

A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
por: Sh Ahmed, Omar, et al.
Publicado: (2022)

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma
por: Pal, Krishnendu, et al.
Publicado: (2022)

Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component
por: Zhang, Shirong, et al.
Publicado: (2021)

Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma
por: Miao, Fang, et al.
Publicado: (2021)

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma
por: Hu, Qin, et al.
Publicado: (2022)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

Metastatic ductal adenocarcinoma of the breast presenting with pericardial effusion—Challenges in the diagnosis of breast cancer
por: Chahin, Michael, et al.
Publicado: (2019)

Papillary Adenocarcinoma: A Rare Subtype of Lung Adenocarcinoma
por: Thouil, Afaf, et al.
Publicado: (2023)

Editorial: Molecular landscapes of human papillomavirus-related squamous cell carcinoma
por: Shen, Yujie, et al.
Publicado: (2023)

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma
por: Yuan, Didi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6kr2l8o4l6669c7105r9ef9rll